Anemia in the intensive care unit.
Vincent JL
Can J Anaesth 2003;50(6):S53-S59.
Review by
Anemia and postoperative rehabilitation.
Carson JL, Terrin ML, Magaziner J
Can J Anaesth 2003;50(6):S60-S64.
Review by
Erythropoietin, uncertainty principle and cancer related anaemia.
Clark O, Adams JR, Bennett CL, Djulbegovic B
BMC Cancer 2002;2(1):23.
Review by
Combining anchor and distribution-based methods to derive minimal clinically important differences on the functional assessment of cancer therapy (FACT) anemia and fatigue scales.
Cella D, Eton DT, Lai JS, Peterman AH, Merkel DE
J Pain Symptom Manage 2002;24(6):547-561.
Review by Ford PA
The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study.
Scott SN, Boeve TJ, McCulloch TM, Fitzpatrick KA, Karnell LH
Laryngoscope 2002;112(7):1221-1229.
Review by Henry DH
New approach to management of life-threatening bleeding in a Jehovah’s Witness.
Hickey R
Crit Care Med 2002;30(8):1930-1931.
Review by Hardy JF
The clinical value of erythropoietin in patients with cancer.
Duhrsen U
Drugs 2002;62(14):2013-2023.
Review by
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology.
Rizzo JD, Lichtin AE, Woolf SH, et al.
Blood 2002;100(7):2303-2320.
Review by
Severe anemia after gastrointestinal hemorrhage in a Jehovah’s Witness: new treatment strategies.
Gannon CJ, Napolitano LM
Crit Care Med 2002;30(8):1893-1895.
Review by Hardy JF**
Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion.
Kooistra MP, Kersting S, Gosriwatana I, et al.
Eur J Clin Invest 2002;32:36-41:36-41.
Reduction in erythropoietin doses by the use of chronic intravenous iron supplementation in iron-replete hemodialysis patients.
Chang CH, Chang CC, Chiang SS
Clin Nephrol 2002;57(2):136-141.
Review by Gasche C
Perioperative anemia: An independent risk factor for infection, mortality, and resource utilization in surgery.
Dunne JR, Malone D, Tracy JK, Gannon C, Napolitano LM
J Surg Res 2002;102(2):237-244.
Review by
A randomized trial of iron deficiency testing strategies in hemodialysis patients.
Fishbane S, Shapiro W, Dutka P, Valenzuela OF, Faubert J
Kidney Int 2001;60(6):2406-2411.
Review by
The effect of i.v. iron alone or in combination with low- dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Silverberg DS, Blum M, Agbaria Z, et al.
Clin Nephrol 2001;55(3):212-219.
Considerations for optimal iron use for anemia due to chronic kidney disease.
Hudson JQ, Comstock TJ
Clin Ther 2001;23(10):1637-1671.
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659